News

MedPage Today on MSN1d
DAPT After TAVR: Harm Bleeds Into Mortality Territory
However, guidelines already recommend that antithrombotics after TAVR consist of lifelong SAPT (aspirin 75-100 mg daily or ...
Early transcatheter aortic valve replacement reduces cardiovascular events in asymptomatic aortic stenosis patients
New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...
Single antiplatelet therapy reduced risk in patients undergoing transcatheter aortic valve replacement by half
Findings from the Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry demonstrate that ...
MassDevice2d
Edwards wins FDA nod for TAVR in aortic stenosis without symptoms
Edwards Lifesciences (NYSE: EW) received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.
TCTMD2d
FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis
The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.
MedPage Today on MSN2d
FDA Approves Sapien 3 TAVR for Asymptomatic Aortic Stenosis
FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...
EurekAlert!3d
Single antiplatelet therapy reduced risk of mortality and major bleeding in patients undergoing transcatheter aortic valve replacement by half
Findings from the Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry demonstrate that ...